Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00333970 · ClinicalTrials.gov registry record · NA

Predictors of Response to Cognitive Remediation in Schizophrenia

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
103
Enrollment target

NCT00333970: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00333970 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00333970, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target

Study Summary

The purpose of this study is to determine which variables predict improvement on a cognitive training task battery, used for patients with schizophrenia, and to determine the proportion of patients whose performance returns to normal following cognitive training

Primary Outcome

Change in verbal memory scores from baseline to end of active phase (2 months), measured as trials 1-5 total score on the California Verbal Learning Test -II (range 0-80, higher scores represent better performance).

Interventions

  • BEHAVIORAL cognitive remediation

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2004-08
Est. Completion 2014-07
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00333970 record still lists

NCT00333970 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which cognitive remediation is the first listed.

NCT00333970 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00333970 about?

NCT00333970 is a clinical study titled "Predictors of Response to Cognitive Remediation in Schizophrenia". The purpose of this study is to determine which variables predict improvement on a cognitive training task battery, used for patients with schizophrenia, and to determine the proportion of patients whose performance returns to normal following cognitive training

What is the current status of trial NCT00333970?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2004-08. Estimated completion is 2014-07.

What interventions are being tested in trial NCT00333970?

The interventions under investigation include: cognitive remediation (BEHAVIORAL).

Who is sponsoring clinical trial NCT00333970?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00333970's enrollment target sits among peer trials

103 837th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04690348 · 103 participants · Phase 2

    Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

  • NCT05282277 · 103 participants · Phase 4

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

  • NCT05566769 · 103 participants · NA

    Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  • NCT05834478 · 103 participants · Phase 3

    Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00333970, the US trial registry maintained by the National Library of Medicine. NCT00333970 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.